Impact of curcumin on p38 MAPK: therapeutic implications

[1]  A. Sahebkar,et al.  Protective effects of curcumin against traumatic brain injury. , 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[2]  G. Sheu,et al.  Curcumin Induces Apoptosis of Chemoresistant Lung Cancer Cells via ROS-Regulated p38 MAPK Phosphorylation , 2022, International journal of molecular sciences.

[3]  Mingyu Xia,et al.  Synthesis and Anti-Neuroinflammatory Activity of 1,7-diphenyl-1,4-heptadien-3-ones in LPS-Stimulated BV2 Microglia Via Inhibiting NF-κB/MAPK Signaling Pathways , 2022, Molecules.

[4]  Ya-jun Deng,et al.  Curcumin suppress inflammatory response in traumatic brain injury via p38/MAPK signaling pathway , 2022, Phytotherapy research : PTR.

[5]  A. Sahebkar,et al.  Curcumin supplementation in pediatric patients: A systematic review of current clinical evidence , 2021, Phytotherapy research : PTR.

[6]  M. Balbaa,et al.  Ameliorative effect of curcumin and zinc oxide nanoparticles on multiple mechanisms in obese rats with induced type 2 diabetes , 2021, Scientific Reports.

[7]  A. Mahmoud,et al.  Nano-Curcumin Prevents Cardiac Injury, Oxidative Stress and Inflammation, and Modulates TLR4/NF-κB and MAPK Signaling in Copper Sulfate-Intoxicated Rats , 2021, Antioxidants.

[8]  A. Kunnumakkara,et al.  Safety assessment of a highly bioavailable curcumin-galactomannoside complex (CurQfen) in healthy volunteers, with a special reference to the recent hepatotoxic reports of curcumin supplements: A 90-days prospective study , 2021, Toxicology reports.

[9]  P. Amin,et al.  Development of Gelucire® 48/16 and TPGS Mixed Micelles and Its Pellet Formulation by Extrusion Spheronization Technique for Dissolution Rate Enhancement of Curcumin , 2021, AAPS PharmSciTech.

[10]  A. Sahebkar,et al.  Effect of curcumin on proinflammatory cytokines: A meta-analysis of randomized controlled trials. , 2021, Cytokine.

[11]  Bo Wang,et al.  Curcumin improves insulin sensitivity and increases energy expenditure in high-fat-diet-induced obese mice associated with activation of FNDC5/irisin. , 2021, Nutrition.

[12]  A. Sahebkar,et al.  Effects of phytochemicals on macrophage cholesterol efflux capacity: Impact on atherosclerosis , 2021, Phytotherapy research : PTR.

[13]  F. Shidfar,et al.  Effects of curcumin supplementation on blood glucose, insulin resistance and androgens in patients with polycystic ovary syndrome: A randomized double-blind placebo-controlled clinical trial. , 2020, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[14]  Elise Adrian Ostrander,et al.  Turmeric and Its Major Compound Curcumin on Health: Bioactive Effects and Safety Profiles for Food, Pharmaceutical, Biotechnological and Medicinal Applications , 2020, Frontiers in Pharmacology.

[15]  M. Corbo,et al.  Obstacles against the Marketing of Curcumin as a Drug , 2020, International journal of molecular sciences.

[16]  Liming Cheng,et al.  Solid lipid nanoparticles enhanced the neuroprotective role of curcumin against epilepsy through activation of Bcl-2 family and P38 MAPK pathway. , 2020, ACS chemical neuroscience.

[17]  Tannaz Jamialahmadi,et al.  Curcumin: an inflammasome silencer. , 2020, Pharmacological research.

[18]  Ying-chun Meng,et al.  Curcumin alleviates OGD/R-induced PC12 cell damage via repressing CCL3 and inactivating TLR4/MyD88/MAPK/NF-κB to suppress inflammation and apoptosis. , 2020, The Journal of pharmacy and pharmacology.

[19]  E. El-Ahwany,et al.  Effects of free and nanoparticulate curcumin on chemically induced liver carcinoma in an animal model , 2020, Archives of medical science : AMS.

[20]  R. Mohammadinejad,et al.  Potential therapeutic effects of curcumin mediated by JAK/STAT signaling pathway: A review. , 2020, Phytotherapy research : PTR.

[21]  E. de Nadal,et al.  The p38 Pathway: From Biology to Cancer Therapy , 2020, International journal of molecular sciences.

[22]  Joungmin Kim,et al.  Protective role of curcumin against lipopolysaccharide-induced inflammation and apoptosis in human neutrophil , 2020, Anesthesia and pain medicine.

[23]  A. Avan,et al.  Curcumin inhibits NF-kB and Wnt/β-catenin pathways in cervical cancer cells. , 2019, Pathology, research and practice.

[24]  C. Subhramanyam,et al.  Microglia-mediated neuroinflammation in neurodegenerative diseases. , 2019, Seminars in cell & developmental biology.

[25]  Devanand L. Luthria,et al.  Curcumin: Biological, Pharmaceutical, Nutraceutical, and Analytical Aspects , 2019, Molecules.

[26]  M. Djalali,et al.  Molecular Mechanisms of Curcumin in Neuroinflammatory Disorders: A Mini Review of Current Evidences. , 2019, Endocrine, metabolic & immune disorders drug targets.

[27]  Peng-Chong Wang,et al.  Neuroprotective Effects of Curcumin on IL-1β-Induced Neuronal Apoptosis and Depression-Like Behaviors Caused by Chronic Stress in Rats , 2019, Front. Cell. Neurosci..

[28]  A. Avan,et al.  Phytosomal curcumin inhibits tumor growth in colitis‐associated colorectal cancer , 2018, Journal of cellular physiology.

[29]  Amirhossein Sahebkar,et al.  Therapeutic potential of curcumin in diabetic complications , 2018, Pharmacological research.

[30]  Jinquan Cheng,et al.  Curcumin Inhibits Acute Vascular Inflammation through the Activation of Heme Oxygenase-1 , 2018, Oxidative medicine and cellular longevity.

[31]  Erran L. Li,et al.  Curcumin attenuates chronic intermittent hypoxia-induced brain injuries by inhibiting AQP4 and p38 MAPK pathway , 2018, Respiratory Physiology & Neurobiology.

[32]  Wenyuan Gao,et al.  Curcumin enhances the anti‐cancer effects of Paris Saponin II in lung cancer cells , 2018, Cell proliferation.

[33]  R. Jamwal.  Bioavailable curcumin formulations: A review of pharmacokinetic studies in healthy volunteers. , 2018, Journal of integrative medicine.

[34]  S. Atkin,et al.  The protective role of curcumin in myocardial ischemia–reperfusion injury , 2018, Journal of cellular physiology.

[35]  A. Sahebkar,et al.  Curcumin, hemostasis, thrombosis, and coagulation , 2018, Journal of cellular physiology.

[36]  A. Salimi.  Liposomes as a Novel Drug Delivery System: Fundamental and Pharmaceutical Application , 2018 .

[37]  A. Tedesco,et al.  Local administration of curcumin-loaded nanoparticles effectively inhibits inflammation and bone resorption associated with experimental periodontal disease , 2018, Scientific Reports.

[38]  Sun Young Park,et al.  Anti-inflammatory Effects of Curcumin in Microglial Cells , 2018, Front. Pharmacol..

[39]  E. Meiyanto,et al.  Curcumin targets multiple enzymes involved in the ROS metabolic pathway to suppress tumor cell growth , 2018, Scientific Reports.

[40]  A. Sahebkar,et al.  Protective effects of curcumin against doxorubicin-induced toxicity and resistance: A review. , 2018, Critical reviews in oncology/hematology.

[41]  K. Abe,et al.  CNB‐001, a synthetic pyrazole derivative of curcumin, suppresses lipopolysaccharide‐induced nitric oxide production through the inhibition of NF‐&kgr;B and p38 MAPK pathways in microglia , 2018, European journal of pharmacology.

[42]  A. Sahebkar,et al.  Curcumin: A natural modulator of immune cells in systemic lupus erythematosus. , 2017, Autoimmunity reviews.

[43]  A. Kunnumakkara,et al.  Comparative Oral Absorption of Curcumin in a Natural Turmeric Matrix with Two Other Curcumin Formulations: An Open‐label Parallel‐arm Study , 2017, Phytotherapy research : PTR.

[44]  S. Chaudhury,et al.  Role of Curcumin in Treatment of Alzheimer Disease , 2017 .

[45]  Aizhong Wang,et al.  Curcumin alleviates lipopolysaccharide induced sepsis and liver failure by suppression of oxidative stress-related inflammation via PI3K/AKT and NF-κB related signaling. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[46]  Y. Wen,et al.  Curcumin exerts antitumor effects in retinoblastoma cells by regulating the JNK and p38 MAPK pathways. , 2016, International journal of molecular medicine.

[47]  S. Raha,et al.  Benzo(a)pyrene Induced p53 Mediated Male Germ Cell Apoptosis: Synergistic Protective Effects of Curcumin and Resveratrol , 2016, Front. Pharmacol..

[48]  Y. Panahi,et al.  Effects of curcumin on serum cytokine concentrations in subjects with metabolic syndrome: A post-hoc analysis of a randomized controlled trial. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[49]  R. Sivamani,et al.  Effects of Turmeric (Curcuma longa) on Skin Health: A Systematic Review of the Clinical Evidence , 2016, Phytotherapy research : PTR.

[50]  A. Sahebkar,et al.  Difluorinated Curcumin: A Promising Curcumin Analogue with Improved Anti-Tumor Activity and Pharmacokinetic Profile. , 2016, Current pharmaceutical design.

[51]  Reza Kazemi Oskuee,et al.  Novel delivery system for natural products: Nano-curcumin formulations , 2016, Avicenna journal of phytomedicine.

[52]  Subhashini,et al.  Intranasal curcumin ameliorates airway inflammation and obstruction by regulating MAPKinase activation (p38, Erk and JNK) and prostaglandin D2 release in murine model of asthma. , 2016, International immunopharmacology.

[53]  Jing-jing Hu,et al.  Curcumin induces the apoptosis of A549 cells via oxidative stress and MAPK signaling pathways. , 2015, International journal of molecular medicine.

[54]  Xi Zheng,et al.  Curcumin, Inflammation, and Chronic Diseases: How Are They Linked? , 2015, Molecules.

[55]  A. Nebreda,et al.  Roles of p38α mitogen‐activated protein kinase in mouse models of inflammatory diseases and cancer , 2015, The FEBS journal.

[56]  Paula Saiz de Cos,et al.  Cúrcuma I (Curcuma longa L.) , 2014 .

[57]  A. Sahebkar,et al.  Impact of Supplementation with Curcuminoids on Systemic Inflammation in Patients with Knee Osteoarthritis: Findings from a Randomized Double-Blind Placebo-Controlled Trial , 2014, Drug Research.

[58]  John H. Zhang,et al.  Curcumin inhibits microglia inflammation and confers neuroprotection in intracerebral hemorrhage. , 2014, Immunology letters.

[59]  F. Zheng,et al.  Extracellular signal-regulated kinase signaling-mediated induction and interaction of FOXO3a and p53 contribute to the inhibition of nasopharyngeal carcinoma cell growth by curcumin , 2014, International journal of oncology.

[60]  P. Tuchinda,et al.  Curcumin I Mediates Neuroprotective Effect Through Attenuation of Quinoprotein Formation, p‐p38 MAPK Expression, and Caspase‐3 Activation in 6‐Hydroxydopamine Treated SH‐SY5Y Cells , 2014, Phytotherapy research : PTR.

[61]  Labchan Rajbhandari,et al.  Curcumin protects axons from degeneration in the setting of local neuroinflammation , 2014, Experimental Neurology.

[62]  Jacob M. Wilson,et al.  Comparative absorption of curcumin formulations , 2014, Nutrition Journal.

[63]  F. Zheng,et al.  Targeting EP4 by curcumin through cross talks of AMP-dependent kinase alpha and p38 mitogen-activated protein kinase signaling: the role of PGC-1α and Sp1. , 2013, Cellular signalling.

[64]  L. C. Spolidorio,et al.  Curcumin abrogates LPS-induced pro-inflammatory cytokines in RAW 264.7 macrophages. Evidence for novel mechanisms involving SOCS-1, -3 and p38 MAPK. , 2013, Archives of oral biology.

[65]  Jin‐Ming Lin,et al.  Analysis of keto-enol tautomers of curcumin by liquid chromatography/mass spectrometry , 2013 .

[66]  Y. Makino,et al.  Novel curcumin oral delivery systems. , 2013, Anticancer research.

[67]  E. Waldman,et al.  Topical curcumin for the prevention of oral mucositis in pediatric patients: case series. , 2013, Alternative therapies in health and medicine.

[68]  Y. Topcu-Tarladacalisir,et al.  Effects of curcumin on apoptosis and oxidoinflammatory regulation in a rat model of acetic acid-induced colitis: the roles of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase. , 2013, Journal of medicinal food.

[69]  Xiao-guang Chen,et al.  Curcumin induces FasL-related apoptosis through p38 activation in human hepatocellular carcinoma Huh7 cells. , 2013, Life sciences.

[70]  G. Asher,et al.  Clinical utility of curcumin extract. , 2013, Alternative therapies in health and medicine.

[71]  A. Nebreda,et al.  SnapShot: p38 MAPK Signaling , 2013, Cell.

[72]  J. Vishwanatha,et al.  Scale up, optimization and stability analysis of Curcumin C3 complex-loaded nanoparticles for cancer therapy , 2012, Journal of Nanobiotechnology.

[73]  Sreenu Bhanoth,et al.  New polymorphs of curcumin. , 2011, Chemical communications.

[74]  M. Fujita,et al.  Innovative preparation of curcumin for improved oral bioavailability. , 2011, Biological & pharmaceutical bulletin.

[75]  G. Belcaro,et al.  Efficacy and safety of Meriva®, a curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients. , 2010, Alternative medicine review : a journal of clinical therapeutic.

[76]  Jiuhong Kang,et al.  Curcumin p38-dependently enhances the anticancer activity of valproic acid in human leukemia cells. , 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[77]  A. Sahebkar.  Molecular mechanisms for curcumin benefits against ischemic injury. , 2010, Fertility and sterility.

[78]  A. Cuadrado,et al.  Mechanisms and functions of p38 MAPK signalling. , 2010, The Biochemical journal.

[79]  J. H. Kim,et al.  Curcumin stimulates glucose uptake through AMPK‐p38 MAPK pathways in L6 myotube cells , 2010, Journal of cellular physiology.

[80]  C. Giacomantonio,et al.  Curcumin-Induced Apoptosis in PC3 Prostate Carcinoma Cells Is Caspase-Independent and Involves Cellular Ceramide Accumulation and Damage to Mitochondria , 2010, Nutrition and cancer.

[81]  Jiahuai Han,et al.  MAPK signaling in inflammation-associated cancer development , 2010, Protein & Cell.

[82]  C. Giacomantonio,et al.  Curcumin‐induced apoptosis in ovarian carcinoma cells is p53‐independent and involves p38 mitogen‐activated protein kinase activation and downregulation of Bcl‐2 and survivin expression and Akt signaling , 2010, Molecular carcinogenesis.

[83]  J. Epstein,et al.  Curcumin suppresses p38 mitogen-activated protein kinase activation, reduces IL-1β and matrix metalloproteinase-3 and enhances IL-10 in the mucosa of children and adults with inflammatory bowel disease , 2009, British Journal of Nutrition.

[84]  E. Wagner,et al.  Signal integration by JNK and p38 MAPK pathways in cancer development , 2009, Nature Reviews Cancer.

[85]  S. Burchill,et al.  p38(MAPK): stress responses from molecular mechanisms to therapeutics. , 2009, Trends in molecular medicine.

[86]  D. Binion,et al.  Vascular cell adhesion molecule-1 expression in human intestinal microvascular endothelial cells is regulated by PI 3-kinase/Akt/MAPK/NF-kappaB: inhibitory role of curcumin. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[87]  Y. Li,et al.  Curcumin, a potential inhibitor of up-regulation of TNF-alpha and IL-6 induced by palmitate in 3T3-L1 adipocytes through NF-kappaB and JNK pathway. , 2009, Biomedical and environmental sciences : BES.

[88]  D. Binion,et al.  Curcumin inhibits VEGF-mediated angiogenesis in human intestinal microvascular endothelial cells through COX-2 and MAPK inhibition , 2008, Gut.

[89]  M. Mattson,et al.  Curcumin Stimulates Proliferation of Embryonic Neural Progenitor Cells and Neurogenesis in the Adult Hippocampus* , 2008, Journal of Biological Chemistry.

[90]  Wei Wang,et al.  Neuroprotective effect of curcumin on focal cerebral ischemic rats by preventing blood-brain barrier damage. , 2007, European journal of pharmacology.

[91]  E. Talero,et al.  Curcumin, a Curcuma longa constituent, acts on MAPK p38 pathway modulating COX-2 and iNOS expression in chronic experimental colitis. , 2007, International immunopharmacology.

[92]  Murugesan V. S. Rajaram,et al.  Curcumin induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by modulating akt and p38 mAPK , 2007, Cancer biology & therapy.

[93]  Azad Bonni,et al.  p38 MAP Kinase Mediates Apoptosis through Phosphorylation of BimEL at Ser-65* , 2006, Journal of Biological Chemistry.

[94]  B. Jang,et al.  Curcumin inhibits the expression of COX-2 in UVB-irradiated human keratinocytes (HaCaT) by inhibiting activation of AP-1: p38 MAP kinase and JNK as potential upstream targets , 2005, Experimental & Molecular Medicine.

[95]  J. Blenis,et al.  ERK and p38 MAPK-Activated Protein Kinases: a Family of Protein Kinases with Diverse Biological Functions , 2004, Microbiology and Molecular Biology Reviews.

[96]  A. Gomez-Muñoz,et al.  Curcumin attenuates DNB-induced murine colitis. , 2003, American journal of physiology. Gastrointestinal and liver physiology.

[97]  N. Chainani-Wu.  Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa). , 2003, Journal of alternative and complementary medicine.

[98]  P. Lograsso,et al.  Signalling for survival and death in neurones: the role of stress-activated kinases, JNK and p38. , 2001, Cellular signalling.

[99]  K. Abe,et al.  The Synthetic Curcumin Derivative CNB-001 Attenuates Thrombin-Stimulated Microglial Inflammation by Inhibiting the ERK and p38 MAPK Pathways. , 2020, Biological & pharmaceutical bulletin.

[100]  Zupeng Chen,et al.  Neuroprotective Effect of Curcumin Against Cerebral Ischemia-Reperfusion Via Mediating Autophagy and Inflammation , 2017, Journal of Molecular Neuroscience.

[101]  A. K. Dutta.  Novel Drug Delivery Systems to Improve Bioavailability of Curcumin , 2014 .

[102]  N. Vallianou,et al.  CURCUMIN AND DIABETES: MECHANISMS OF ACTION AND ITS ANTI-DIABETIC PROPERTIES , 2014 .

[103]  Min Han 韩 敏,et al.  Downregulation of p38 MAPK involved in inhibition of LDL-induced proliferation of mesangial cells and matrix by curcumin , 2013, Journal of Huazhong University of Science and Technology [Medical Sciences].

[104]  A. Shehzad,et al.  Curcumin in inflammatory diseases , 2013, BioFactors.

[105]  M. Saurabh,et al.  STUDY OF FORMULATION, CHARACTERISATION AND WOUND HEALING POTENTIAL OF TRANSDERMAL PATCHES OF CURCUMIN , 2012 .

[106]  G. Fanger,et al.  Regulation of the MAPK family members : Role of subcellular localization and architectural organization , 2011 .

[107]  Xiuzu Song,et al.  AMPK mediates curcumin-induced cell death in CaOV3 ovarian cancer cells. , 2008, Oncology reports.

[108]  V. Menon,et al.  Antioxidant and anti-inflammatory properties of curcumin. , 2007, Advances in experimental medicine and biology.

[109]  G. Kuttan,et al.  Antitumor, anti-invasion, and antimetastatic effects of curcumin. , 2007, Advances in experimental medicine and biology.

[110]  Chih-Hung Hsu,et al.  Clinical studies with curcumin. , 2007, Advances in experimental medicine and biology.

[111]  B. Aggarwal,et al.  The molecular targets and therapeutic uses of curcumin in health and disease , 2007 .

[112]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..